Conversely, the absence of gp130 in hepatocytes results in decreased IL-6 and OSM expression, constitutive phosphorylation of STAT5 and subsequently impaired TGFβ-dependent signaling, thereby attenuating HCC development (Figure 8). The gene discussed is TGFB1; the disease is hepatocellular carcinoma.